Healthcare Realty Trust (NYSE:HR) Lowered to “Sell” Rating by Wall Street Zen

Wall Street Zen lowered shares of Healthcare Realty Trust (NYSE:HR) from a hold rating to a sell rating in a research note issued to investors on Friday morning.

A number of other research analysts also recently commented on HR. BTIG Research reiterated a “buy” rating and set a $20.00 price objective on shares of Healthcare Realty Trust in a research note on Monday, September 29th. Wells Fargo & Company increased their price target on shares of Healthcare Realty Trust from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. Cantor Fitzgerald assumed coverage on Healthcare Realty Trust in a report on Wednesday, October 1st. They issued an “overweight” rating and a $23.00 price objective for the company. Weiss Ratings restated a “hold (c)” rating on shares of Healthcare Realty Trust in a research note on Monday, December 29th. Finally, Royal Bank Of Canada began coverage on Healthcare Realty Trust in a report on Wednesday, October 8th. They set a “sector perform” rating and a $19.00 target price on the stock. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $19.13.

Healthcare Realty Trust Stock Up 0.7%

Shares of NYSE HR opened at $17.09 on Friday. Healthcare Realty Trust has a fifty-two week low of $14.09 and a fifty-two week high of $18.97. The business has a 50 day moving average price of $17.34 and a two-hundred day moving average price of $17.37. The firm has a market cap of $6.01 billion, a PE ratio of -16.12 and a beta of 0.96.

Healthcare Realty Trust (NYSE:HR) last announced its earnings results on Thursday, October 30th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Healthcare Realty Trust had a negative return on equity of 7.32% and a negative net margin of 30.51%.The company had revenue of $297.77 million for the quarter, compared to analyst estimates of $291.10 million. During the same period in the prior year, the company posted $0.39 EPS. Healthcare Realty Trust’s quarterly revenue was down 6.2% on a year-over-year basis. Healthcare Realty Trust has set its FY 2025 guidance at 1.590-1.60 EPS. On average, analysts anticipate that Healthcare Realty Trust will post 1.59 earnings per share for the current year.

Healthcare Realty Trust Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 21st. Shareholders of record on Tuesday, November 11th were given a $0.24 dividend. The ex-dividend date of this dividend was Monday, November 10th. This represents a $0.96 annualized dividend and a yield of 5.6%. Healthcare Realty Trust’s dividend payout ratio (DPR) is currently -90.57%.

Hedge Funds Weigh In On Healthcare Realty Trust

Institutional investors have recently modified their holdings of the company. Wiser Advisor Group LLC bought a new stake in Healthcare Realty Trust in the 3rd quarter valued at about $25,000. Smartleaf Asset Management LLC raised its holdings in shares of Healthcare Realty Trust by 179.7% during the third quarter. Smartleaf Asset Management LLC now owns 1,608 shares of the real estate investment trust’s stock valued at $29,000 after buying an additional 1,033 shares during the last quarter. Atlantic Union Bankshares Corp bought a new stake in shares of Healthcare Realty Trust during the third quarter valued at approximately $32,000. Financial Gravity Companies Inc. acquired a new position in shares of Healthcare Realty Trust during the second quarter worth approximately $45,000. Finally, Danske Bank A S bought a new position in Healthcare Realty Trust in the 3rd quarter worth approximately $47,000.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.